Figure 6
Figure 6. Coagulation markers. Mean (± SE) plasma levels of TATc (A) and soluble TF (B) after LPS administration (4 ng/kg intravenously, T = 0 hours), during one of the following conditions: an LinsuEgluc clamp (□), an LinsuHgluc clamp (○), an HinsuEgluc clamp (■), and an HinsuHgluc clamp (●). *P < .05 and ***P < .001 hyperglycemic versus euglycemic clamps; †P < .05 hyperinsulinemic versus lower insulinemic clamps.

Coagulation markers. Mean (± SE) plasma levels of TATc (A) and soluble TF (B) after LPS administration (4 ng/kg intravenously, T = 0 hours), during one of the following conditions: an LinsuEgluc clamp (□), an LinsuHgluc clamp (○), an HinsuEgluc clamp (■), and an HinsuHgluc clamp (●). *P < .05 and ***P < .001 hyperglycemic versus euglycemic clamps; †P < .05 hyperinsulinemic versus lower insulinemic clamps.

Close Modal

or Create an Account

Close Modal
Close Modal